MetaboGen is granted US diabetes patent
MetaboGen AB has on January 30th, 2018 been granted a US patent for the identification of a person at risk for developing type 2 diabetes (...) Read the full story
MetaboGen AB has on January 30th, 2018 been granted a US patent for the identification of a person at risk for developing type 2 diabetes (...) Read the full story